Markets · Stocks & ETFs · ADR

JBS (NYSE: JBS)

$11.91-1.00%today

Brazilian ADR trading on the NYSE, priced in US dollars. Key figures below are sourced from Yahoo Finance.

Market Cap
$39.17B
P/E (TTM)
7.4x
P/B
1.5x
EPS (TTM)
1.60
Dividend Yield
11.16%
52-Week Range
$11.49 – $18.65
Volume
3.69M
Previous Close
$12.03

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today
-1.00%
1 Week
+0.00%
1 Month
-0.17%
YTD
-17.41%
1 Year
-9.70%
5 Years
JBS logo

About JBS

US Ticker
JBS
B3 Ticker
JBSS3
Exchange
NYSE
Currency
USD
Sector
Consumer Defensive
Industry
Packaged Foods
Headquarters
Amstelveen, Netherlands
Employees
283,000
CEO
Mr. Gilberto Tomazoni
Founded
1953

JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide.

The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses.

It offers its products under the Seara, Doriana, Pilgrim's, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, Adaptable Meals, and other brand names.

The company was founded in 1953 and is based in Amstelveen, the Netherlands.

jbsglobal.com

Analyst Ratings

Consensus of 14 Wall Street analysts · sourced from Yahoo Finance

1.5Buy

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low
$15.32
Average
$19.09
High
$22.09

The average target is +60.29% above the current price of $11.91.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from JBS's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Solid

Net Margin
2.0%
ROE
22.5%
Rev Growth (YoY)
+1.30%
Net Debt / EBITDA
2.92×
Current Ratio
1.50×
Interest Coverage
3.09×
Free Cash Flow
2.29B
Payout Ratio
76.4%

Income — Margins & Efficiency

MetricLast 12MQ2'25 – Q1'26Δ2025Δ2024Δ2023Δ2022
Revenue$477,262,889,000+1.3%$471,142,859,000+13.0%$416,952,002,000+14.6%$363,816,537,000-5.2%$383,967,833,000
Gross profit$58,775,394,000-2.6%$60,327,321,000-3.9%$62,772,967,000+58.3%$39,648,997,000-35.0%$61,040,634,000
Operating income$20,359,620,000-10.0%$22,628,287,000-4.8%$23,763,417,000+348.2%$5,302,294,000-79.0%$25,293,615,000
EBITDA$35,037,916,000-3.2%$36,209,252,000+2.3%$35,385,882,000+140.4%$14,718,649,000-59.1%$35,977,662,000
Net profit$9,545,587,000-14.0%$11,096,825,000+15.4%$9,615,923,000+1006.3%-$1,060,972,000-106.7%$15,850,117,000
Gross margin12.3%-0.5 p.p.12.8%-2.3 p.p.15.1%+4.2 p.p.10.9%-5.0 p.p.15.9%
Operating margin4.3%-0.5 p.p.4.8%-0.9 p.p.5.7%+4.2 p.p.1.5%-5.1 p.p.6.6%
EBITDA margin7.3%-0.3 p.p.7.7%-0.8 p.p.8.5%+4.4 p.p.4.0%-5.3 p.p.9.4%
Net margin2.0%-0.4 p.p.2.4%+0.0 p.p.2.3%+2.6 p.p.-0.3%-4.4 p.p.4.1%
Revenue growth (YoY)1.3%-11.7 p.p.13.0%-1.6 p.p.14.6%+19.9 p.p.-5.2%-11.2 p.p.5.9%
Effective tax rate14.2%-0.9 p.p.15.1%-12.7 p.p.27.8%-20.1 p.p.47.8%+36.3 p.p.11.5%
Interest coverage3.09×+20.4%2.57×-83.5%15.60×+353.5%3.44×-82.2%19.28×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

MetricLast 12MQ2'25 – Q1'26Δ2025Δ2024Δ2023Δ2022
Net debt$102,346,384,000+1.7%$100,603,322,000-83.8%$619,425,295,000+42.9%$433,532,702,000+375.2%$91,227,010,000
Net Debt / Equity2.41×+14.7%2.10×-6.0%2.24×+9.9%2.03×+3.4%1.97×
Net Debt / EBITDA2.92×+5.1%2.78×-84.1%17.50×-40.6%29.45×+1061.6%2.54×
Debt / Equity2.81×+7.1%2.63×-12.8%3.01×+18.4%2.54×+13.0%2.25×
Current ratio1.50×-5.9%1.60×+8.8%1.47×-10.5%1.64×+14.0%1.44×
Return on equity (ROE)22.5%-0.7 p.p.23.2%+19.7 p.p.3.5%+4.0 p.p.-0.5%-34.7 p.p.34.2%
Return on assets (ROA)4.1%-0.4 p.p.4.5%+3.9 p.p.0.6%+0.7 p.p.-0.1%-7.7 p.p.7.6%
Book value / share$39.38-12.1%$44.80-64.1%$124.85+30.0%$96.06+367.3%$20.56

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $1.00/share · yield 8.40%

Dividends and yield from Yahoo Finance (per ADR share, in USD). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

JBS trades on 2 exchanges. Prices on this page are the NYSE ADR (JBS).

ExchangeTickerCurrency
NYSEpriced hereJBSUSD
B3 (São Paulo)JBSS3BRL

Last updated: 02:27 BRT · Updated hourly during market hours